Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
To determine the most efficacious of two combination regimens of sequential CPT-11 and MMC in
patients with advanced and previously untreated esophageal and GE junction adenocarcinomas.